These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 20484589)
21. DNA copy number changes in alveolar soft part sarcoma: a comparative genomic hybridization study. Kiuru-Kuhlefelt S; El-Rifai W; Sarlomo-Rikala M; Knuutila S; Miettinen M Mod Pathol; 1998 Mar; 11(3):227-31. PubMed ID: 9521467 [TBL] [Abstract][Full Text] [Related]
22. The spatial distribution of monosomy 3 and network vasculogenic mimicry patterns in uveal melanoma. Meir T; Zeschnigk M; Masshöfer L; Pe'er J; Chowers I Invest Ophthalmol Vis Sci; 2007 May; 48(5):1918-22. PubMed ID: 17460242 [TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis. van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379 [TBL] [Abstract][Full Text] [Related]
24. Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization. Naus NC; van Drunen E; de Klein A; Luyten GP; Paridaens DA; Alers JC; Ksander BR; Beverloo HB; Slater RM Genes Chromosomes Cancer; 2001 Mar; 30(3):267-73. PubMed ID: 11170284 [TBL] [Abstract][Full Text] [Related]
25. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization. Naus NC; Verhoeven AC; van Drunen E; Slater R; Mooy CM; Paridaens DA; Luyten GP; de Klein A Clin Cancer Res; 2002 Feb; 8(2):534-9. PubMed ID: 11839674 [TBL] [Abstract][Full Text] [Related]
27. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type. Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742 [TBL] [Abstract][Full Text] [Related]
28. Multiplex fluorescence in situ hybridization identifies novel rearrangements of chromosomes 6, 15, and 18 in primary uveal melanoma. Sisley K; Tattersall N; Dyson M; Smith K; Mudhar HS; Rennie IG Exp Eye Res; 2006 Sep; 83(3):554-9. PubMed ID: 16684523 [TBL] [Abstract][Full Text] [Related]
29. [Genomic techniques used in uveal melanoma: a literature review]. Abi-Ayad N; Kodjikian L; Couturier J J Fr Ophtalmol; 2011 Apr; 34(4):259-64. PubMed ID: 21439677 [TBL] [Abstract][Full Text] [Related]
30. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma. Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992 [TBL] [Abstract][Full Text] [Related]
31. Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification. Moelans CB; de Weger RA; van Diest PJ Breast Cancer Res Treat; 2010 Feb; 120(1):1-7. PubMed ID: 19760503 [TBL] [Abstract][Full Text] [Related]
32. Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens. Shields CL; Ganguly A; Bianciotto CG; Turaka K; Tavallali A; Shields JA Ophthalmology; 2011 Feb; 118(2):396-401. PubMed ID: 20869116 [TBL] [Abstract][Full Text] [Related]
33. Cluster analysis of multiplex ligation-dependent probe amplification data in choroidal melanoma. Caines R; Eleuteri A; Kalirai H; Fisher AC; Heimann H; Damato BE; Coupland SE; Taktak AF Mol Vis; 2015; 21():1-11. PubMed ID: 25684974 [TBL] [Abstract][Full Text] [Related]
34. Preliminary results of the FRO project: chromosomal abnormalities in primary uveal melanoma. Cools D; Debiec-Rychter M; Parys-Van Ginderdeuren R; Hagemeijer-Hausman A; Van den Oord J; Spileers W Bull Soc Belge Ophtalmol; 2000; (278):67-70. PubMed ID: 11761564 [TBL] [Abstract][Full Text] [Related]
35. Correlation of comparative genomic hybridization results of 100 archival uveal melanomas with patient survival. White JS; McLean IW; Becker RL; Director-Myska AE; Nath J Cancer Genet Cytogenet; 2006 Oct; 170(1):29-39. PubMed ID: 16965952 [TBL] [Abstract][Full Text] [Related]
36. Low-Pass Whole-Genome Sequencing as a Method of Determining Copy Number Variations in Uveal Melanoma Tissue Samples. Beasley AB; Bentel J; Allcock RJN; Vermeulen T; Calapre L; Isaacs T; Ziman MR; Chen FK; Gray ES J Mol Diagn; 2020 Mar; 22(3):429-434. PubMed ID: 31978561 [TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma. Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185 [TBL] [Abstract][Full Text] [Related]
38. Multiplex Ligation-dependent Probe Amplification (MLPA®) for the detection of copy number variation in genomic sequences. Eijk-Van Os PG; Schouten JP Methods Mol Biol; 2011; 688():97-126. PubMed ID: 20938835 [TBL] [Abstract][Full Text] [Related]
39. Correlation of heterogeneity for chromosome 3 copy number with cell type in choroidal melanoma of mixed-cell type. Sandinha T; Farquharson M; McKay I; Roberts F Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5177-80. PubMed ID: 17122100 [TBL] [Abstract][Full Text] [Related]
40. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma. Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]